Chadtough Defeat Dipg Foundation

About Chadtough Defeat Dipg Foundation

Chadtough Defeat Dipg Foundation centers its grantmaking on research to find a cure for DIPG and DMG, with support extending to affected families. Its recent awards show a strong preference for scientific and clinical work at major research institutions, including a $1,629,755 grant to the University of Michigan and a $1,047,540 grant to the University of California, San Francisco. Other large awards have gone to Dana-Farber Cancer Institute, Duke University, Massachusetts Institute of Technology, and MD Anderson Cancer Center, indicating a portfolio built around pediatric brain cancer research rather than general health funding. The foundation’s program language emphasizes investigator-led projects, fellowships, translational research, and clinical studies. That mix fits a targeted disease-focused strategy: funding individual scientists, supporting collaborative or sponsored projects, and backing work that aims to move from laboratory findings toward treatment. Its named program pages include research grants, fellowship awards, special grants, and game changer awards, all tied to DIPG/DMG. The recipient list is concentrated in established academic medical centers, with repeated support for institutions that can carry out preclinical and translational neuro-oncology research.

What Chadtough Defeat Dipg Foundation Funds

In pediatric brain cancer research, the foundation gave $588,997 to the University of Michigan for research specific to DIPG, after a prior $435,528 award to the Regents of the University of Michigan for the same disease focus. It also supported Dana-Farber Cancer Institute with $385,696 in 2024 for pediatric brain cancer research specific to DIPG, showing sustained interest in institution-based scientific programs. Its portfolio also includes translational and therapeutic work. A $382,900 research grant to Duke University and a $382,560 grant to Massachusetts Institute of Technology both sit within broader research support tied to DIPG. The foundation has also funded projects on immunotherapy and mitochondrial biology, including work described as inhibition of mitochondrial ROS scavenging as a treatment strategy for DMG. Fellowship support is another clear theme. The foundation’s fellowship grant program is designed for pre-doctoral and post-doctoral fellows under mentor guidance, pointing to talent development alongside project funding.

How Chadtough Defeat Dipg Foundation Gives